Unique ID issued by UMIN | UMIN000034935 |
---|---|
Receipt number | R000039834 |
Scientific Title | A Study on the Effect of Test Food on Postprandial Serum Triglyceride level |
Date of disclosure of the study information | 2018/11/21 |
Last modified on | 2019/05/20 10:35:03 |
A Study on the Effect of Test Food on Postprandial Serum Triglyceride level
A Study on the Effect of Test Food on Postprandial Serum Triglyceride level
A Study on the Effect of Test Food on Postprandial Serum Triglyceride level
A Study on the Effect of Test Food on Postprandial Serum Triglyceride level
Japan |
No
Adult |
Others
NO
To examine the effect of test food on postprandial serum triglyceride
Efficacy
Postprandial Serum Triglyceride
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
A test food "B" with high fat diet
A placebo food with high fat diet
20 | years-old | <= |
60 | years-old | >= |
Male and Female
1. Subjects who can understand the trial, make self-judgment and are voluntarily giving written informed consent.
2. Subjects whose fasting serum triglyceride levels are below 150 mg/dL.
3. Subjects who can be considered appropriate for the participation on this exam by study physician.
1. Subjects who have a chronic disease and use medicines continuously.
2. Subjects who use oral medication past one month to treat disease (exclude for headache, menstrual pain, common cold)
3. Subjects who contract or are under treatment for serious diseases (e.g., diabetes, liver disease, kidney disease, and/or heart disease, vascular disease).
4. Subjects who have a history of digestive disease affecting digestion and absorption (exclude for acute appendicitis history).
5. Subjects with high level of anemia
6. Subjects who have declared allergic reaction to ingredients contained in test products.
7. Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating.
8. Subjects who are under treatment for or have a history of drug addiction and/or alcoholism.
9. Subjects who have the possibility to change lifestyle habits during the trial (night work, overseas business trips etc)
10. Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting lipid metabolism in study period.
11. Subjects who have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to the current study.
12. Subjects who currently participating in other human clinical trials or have not passed for 3 months after joining the other human clinical trials
13. Subjects who are judged as unsuitable for the study by the investigator for other reasons.
12
1st name | |
Middle name | |
Last name | Masayasu Ban |
Mizkan Holdings Co., Ltd.
Central Research Institute
2-6 Nakamuracho, Handa, Aichi
0569-24-5139
mban@mizkan.co.jp
1st name | |
Middle name | |
Last name | Atsushi Ishikawa |
Mizkan Holdings Co., Ltd.
Central Research Institute
2-6 Nakamuracho, Handa, Aichi
0569-24-5139
aishikawa@mizkan.co.jp
Mizkan Holdings Co., Ltd.
Mizkan Holdings Co., Ltd.
Profit organization
NO
2018 | Year | 11 | Month | 21 | Day |
Unpublished
12
Completed
2018 | Year | 10 | Month | 23 | Day |
2018 | Year | 10 | Month | 24 | Day |
2018 | Year | 11 | Month | 21 | Day |
2018 | Year | 12 | Month | 15 | Day |
2019 | Year | 02 | Month | 04 | Day |
2018 | Year | 11 | Month | 19 | Day |
2019 | Year | 05 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039834